nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—ADRB1—Amine ligand-binding receptors—HRH3—narcolepsy	0.039	0.039	CbGpPWpGaD
Metoprolol—ADRB2—Amine ligand-binding receptors—HRH3—narcolepsy	0.0381	0.0381	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Other—P2RY11—narcolepsy	0.0356	0.0356	CbGpPWpGaD
Metoprolol—ADRB1—G alpha (s) signalling events—P2RY11—narcolepsy	0.0284	0.0284	CbGpPWpGaD
Metoprolol—ADRB2—G alpha (s) signalling events—P2RY11—narcolepsy	0.0278	0.0278	CbGpPWpGaD
Metoprolol—ADRB1—Monoamine GPCRs—HTR2A—narcolepsy	0.0231	0.0231	CbGpPWpGaD
Metoprolol—ADRB2—Monoamine GPCRs—HTR2A—narcolepsy	0.0226	0.0226	CbGpPWpGaD
Metoprolol—ADRB1—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0194	0.0194	CbGpPWpGaD
Metoprolol—ADRB2—Amine ligand-binding receptors—HTR2A—narcolepsy	0.019	0.019	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0164	0.0164	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0164	0.0164	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.016	0.016	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.016	0.016	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0158	0.0158	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0155	0.0155	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.014	0.014	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.014	0.014	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0137	0.0137	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0137	0.0137	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0136	0.0136	CbGpPWpGaD
Metoprolol—ADRB1—G alpha (s) signalling events—NPS—narcolepsy	0.0133	0.0133	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0133	0.0133	CbGpPWpGaD
Metoprolol—ADRB2—G alpha (s) signalling events—NPS—narcolepsy	0.013	0.013	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0115	0.0115	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0113	0.0113	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—HCRTR2—narcolepsy	0.0107	0.0107	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—HCRTR1—narcolepsy	0.0107	0.0107	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—HCRTR2—narcolepsy	0.0105	0.0105	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—HCRTR1—narcolepsy	0.0105	0.0105	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—P2RY11—narcolepsy	0.0103	0.0103	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0103	0.0103	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—P2RY11—narcolepsy	0.0101	0.0101	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0101	0.0101	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Other—HTR2A—narcolepsy	0.01	0.01	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00894	0.00894	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—HCRT—narcolepsy	0.00878	0.00878	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00875	0.00875	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00874	0.00874	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—HCRT—narcolepsy	0.00859	0.00859	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00855	0.00855	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—PENK—narcolepsy	0.00783	0.00783	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00766	0.00766	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—PENK—narcolepsy	0.00766	0.00766	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—HLA-DQA1—narcolepsy	0.00764	0.00764	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0075	0.0075	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—HLA-DQB1—narcolepsy	0.00715	0.00715	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—TRH—narcolepsy	0.00666	0.00666	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—TRH—narcolepsy	0.00651	0.00651	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00635	0.00635	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00635	0.00635	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00621	0.00621	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00621	0.00621	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00604	0.00604	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00604	0.00604	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00591	0.00591	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00591	0.00591	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—P2RY11—narcolepsy	0.00584	0.00584	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—HRH3—narcolepsy	0.00584	0.00584	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—P2RY11—narcolepsy	0.00571	0.00571	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—HRH3—narcolepsy	0.00571	0.00571	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—HCRTR2—narcolepsy	0.00549	0.00549	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—HCRTR1—narcolepsy	0.00549	0.00549	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	0.00544	0.00544	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—HCRTR2—narcolepsy	0.00537	0.00537	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—HCRTR1—narcolepsy	0.00537	0.00537	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—P2RY11—narcolepsy	0.0053	0.0053	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00527	0.00527	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—P2RY11—narcolepsy	0.00518	0.00518	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—HCRT—narcolepsy	0.00496	0.00496	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—HCRT—narcolepsy	0.00485	0.00485	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—TAC1—narcolepsy	0.00484	0.00484	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—NPS—narcolepsy	0.00484	0.00484	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—TAC1—narcolepsy	0.00473	0.00473	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—NPS—narcolepsy	0.00473	0.00473	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—HCRT—narcolepsy	0.00451	0.00451	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00446	0.00446	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—PENK—narcolepsy	0.00442	0.00442	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—HCRT—narcolepsy	0.00441	0.00441	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00436	0.00436	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—PENK—narcolepsy	0.00433	0.00433	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CHKB—narcolepsy	0.00419	0.00419	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PENK—narcolepsy	0.00402	0.00402	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PENK—narcolepsy	0.00393	0.00393	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00382	0.00382	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—TRH—narcolepsy	0.00376	0.00376	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00374	0.00374	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—TRH—narcolepsy	0.00368	0.00368	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00358	0.00358	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—TRH—narcolepsy	0.00342	0.00342	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—TRH—narcolepsy	0.00334	0.00334	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—HRH3—narcolepsy	0.0033	0.0033	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HCRTR1—narcolepsy	0.00324	0.00324	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HCRTR2—narcolepsy	0.00324	0.00324	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—HRH3—narcolepsy	0.00323	0.00323	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HCRTR2—narcolepsy	0.00317	0.00317	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HCRTR1—narcolepsy	0.00317	0.00317	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—P2RY11—narcolepsy	0.00313	0.00313	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—P2RY11—narcolepsy	0.00306	0.00306	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—HRH3—narcolepsy	0.00299	0.00299	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—HRH3—narcolepsy	0.00293	0.00293	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—HTR2A—narcolepsy	0.00291	0.00291	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CPT1B—narcolepsy	0.00285	0.00285	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—HTR2A—narcolepsy	0.00285	0.00285	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—TAC1—narcolepsy	0.00273	0.00273	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—NPS—narcolepsy	0.00273	0.00273	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—TAC1—narcolepsy	0.00267	0.00267	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—NPS—narcolepsy	0.00267	0.00267	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HCRT—narcolepsy	0.00266	0.00266	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HCRT—narcolepsy	0.0026	0.0026	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—TNF—narcolepsy	0.00257	0.00257	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—TAC1—narcolepsy	0.00248	0.00248	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—NPS—narcolepsy	0.00248	0.00248	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—NPS—narcolepsy	0.00243	0.00243	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—TAC1—narcolepsy	0.00243	0.00243	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PENK—narcolepsy	0.00237	0.00237	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CHKB—narcolepsy	0.00235	0.00235	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PENK—narcolepsy	0.00232	0.00232	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CHKB—narcolepsy	0.00229	0.00229	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CHKB—narcolepsy	0.00216	0.00216	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TRH—narcolepsy	0.00202	0.00202	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TRH—narcolepsy	0.00197	0.00197	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HRH3—narcolepsy	0.00177	0.00177	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HRH3—narcolepsy	0.00173	0.00173	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—HTR2A—narcolepsy	0.00164	0.00164	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—HTR2A—narcolepsy	0.00161	0.00161	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CPT1B—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CPT1B—narcolepsy	0.00156	0.00156	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—HTR2A—narcolepsy	0.00149	0.00149	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CPT1B—narcolepsy	0.00147	0.00147	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NPS—narcolepsy	0.00147	0.00147	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TAC1—narcolepsy	0.00147	0.00147	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—HTR2A—narcolepsy	0.00146	0.00146	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NPS—narcolepsy	0.00143	0.00143	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TAC1—narcolepsy	0.00143	0.00143	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HTR2A—narcolepsy	0.000882	0.000882	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HTR2A—narcolepsy	0.000863	0.000863	CbGpPWpGaD
